Superiority of hyperpolarizing to depolarizing cardioplegia in protection of coronary endothelial function
- 31 October 1997
- journal article
- research article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 114 (4) , 643-650
- https://doi.org/10.1016/s0022-5223(97)70055-2
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Identification of Epoxyeicosatrienoic Acids as Endothelium-Derived Hyperpolarizing FactorsCirculation Research, 1996
- Characterization of endothelium‐derived hyperpolarizing factor as a cytochrome P450‐derived arachidonic acid metabolite in mammals.The Journal of Physiology, 1994
- Cellular pharmacology of potassium channel openers in vascular smooth muscleCardiovascular Research, 1994
- Cold cardioplegia and the K+ channel modulator aprikalim (RP 52891): improved cardioprotection in isolated ischemic rabbit heartsCanadian Journal of Physiology and Pharmacology, 1994
- Elective cardiac arrest with a hyperpolarizing adenosine triphosphate–sensitive potassium channel openerThe Journal of Thoracic and Cardiovascular Surgery, 1993
- Reduction of ischemic damage in isolated rat hearts by the potassium channel opener, RP 52891European Journal of Pharmacology, 1990
- Changes in the calcium current of rat heart ventricular myocytes during development.The Journal of Physiology, 1988
- Acetylcholine releases endothelium‐derived hyperpolarizing factor and EDRF from rat blood vesselsBritish Journal of Pharmacology, 1988
- Endothelium-derived hyperpolarizing a new endogenous inhibitor from the vascular endotheliumTrends in Pharmacological Sciences, 1988
- Endothelium‐dependent hyperpolarization of canine coronary smooth muscleBritish Journal of Pharmacology, 1988